美股市場個股詳情

GERNW GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)

添加自選
  • 1.520
  • 0.0000.00%
延時15分鐘行情收盤價 11/25 16:00 (美東)
0總市值0.00市盈率TTM

關於GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)公司

傑龍公司是一家臨牀階段生物製藥公司,專注於研究和開發癌症治療藥物。公司的在研藥物 Imelstat 正在接受測試,用於治療骨髓增生異常綜合徵,一種血液疾病,和骨髓纖維化,一種影響骨髓的罕見血癌。公司通過合作協議,里程碑,版稅和許可安排獲得收入。傑龍擁有該藥物的各種權利。該公司的業務只有一個分部,即開發腫瘤治療產品。

公司介紹

公司代碼GERNW
公司名稱GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)
上市日期1996/07/30
成立日期1990
CEODr. John A. Scarlett,M.D.
所屬市場粉單
員工數量141
年結日12-31
公司地址919 East Hillsdale Boulevard,Suite 250
城市Foster City
省份加利福尼亞州
國家美國
郵編94404
電話1-650-473-7700

董事高管

  • 姓名
  • 職務
  • 年薪
  • Dr. John A. Scarlett,M.D.
  • Chairman of the Board, Chief Executive Officer and President
  • 492.41萬
  • Scott A. Samuels
  • Executive Vice President, Chief Legal Officer and Corporate Secretary
  • 360.87萬
  • Dr. Faye Feller
  • Executive Vice President and Chief Medical Officer
  • --
  • Michelle Robertson
  • Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 246.97萬
  • Melissa A. Kelly Behrs
  • Executive Vice President, Business Operations and Chief Alliance Officer
  • --
  • Edward E. Koval
  • Executive Vice President and Chief Business Officer
  • --
  • Dr. Andrew J. Grethlein,PhD
  • Executive Vice President and Chief Operating Officer
  • 241.51萬
  • Shannon T. Odam
  • Senior Vice President and Chief People Officer
  • --
  • Anil Kapur
  • Executive Vice President, Corporate Strategy and Chief Commercial Officer
  • --
  • Elizabeth G. O’Farrell
  • Lead Independent Director
  • 37.55萬
  • Dr. V. Bryan Lawlis, PhD
  • Independent Director
  • 36.09萬
  • Dr. Robert J. Spiegel, F.A.C.P.,M.D.
  • Independent Director
  • 35.09萬
  • Dr. Gaurav Aggarwal, M.D.
  • Independent Director
  • 29.08萬
  • Dawn Carter Bir
  • Independent Director
  • 34.31萬
  • John F. McDonald
  • Independent Director
  • 34.84萬
  • Dr. Susan M. Molineaux, PhD
  • Independent Director
  • 34.59萬

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議
美股
綜合熱度
股票代碼
最新價
升跌幅

暫無數據